Terms: = Cervical cancer AND CgA
18 results:
1. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract] [Full Text] [Related]
2. REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of cervical cancer.
Cortés-Sarabia K; Alarcón-Romero LDC; Mendoza-Catalán MÁ; Carpio-Pedroza JC; Castañeda-Saucedo E; Ortuño-Pineda C
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984538
[No Abstract] [Full Text] [Related]
3. Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
Lu J; Li Y; Wang J
Front Cell Infect Microbiol; 2022; 12():916506. PubMed ID: 35909972
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological Features of Intrathyroid Thymic Carcinoma].
Zheng ZG; Sun WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):42-46. PubMed ID: 33663661
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis.
Huang R; Yu L; Zheng C; Liang Q; Suye S; Yang X; Yin H; Ren Z; Shi L; Zhang Z; Chen H; Fu C
Sci Rep; 2020 Sep; 10(1):14975. PubMed ID: 32917946
[TBL] [Abstract] [Full Text] [Related]
6. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract] [Full Text] [Related]
7. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
8. Chlorogenic Acid Interaction with Cisplatin and Oxaliplatin: Studies in cervical Carcinoma Cells.
Catanzaro D; Filippini R; Vianello C; Carrara M; Ragazzi E; Montopoli M
Nat Prod Commun; 2016 Apr; 11(4):499-502. PubMed ID: 27396204
[TBL] [Abstract] [Full Text] [Related]
9. Chromogranin A (cga) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
[TBL] [Abstract] [Full Text] [Related]
10. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases.
Li JD; Zhuang Y; Li YF; Feng YL; Hou JH; Chen L; Zhu AN; Wu QL; Yun JP
J Clin Pathol; 2011 Dec; 64(12):1102-7. PubMed ID: 21965825
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological analysis of nine cases of small cell carcinoma of the uterine cervix].
Deng GH; Zhang X; Wu LY
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):199-202. PubMed ID: 20450588
[TBL] [Abstract] [Full Text] [Related]
13. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
Mikami Y; Kiyokawa T; Hata S; Fujiwara K; Moriya T; Sasano H; Manabe T; Akahira J; Ito K; Tase T; Yaegashi N; Sato I; Tateno H; Naganuma H
Mod Pathol; 2004 Aug; 17(8):962-72. PubMed ID: 15143335
[TBL] [Abstract] [Full Text] [Related]
14. Neuroendocrine marker expression in cervical carcinomas of non-small cell type.
Chavez-Blanco A; Taja-Chayeb L; Cetina L; Chanona-Vilchis G; Trejo-Becerril C; Perez-Cardenas E; Segura-Pacheco B; Acuña-González C; Dueñas-Gonzalez A
Int J Gynecol Pathol; 2002 Oct; 21(4):368-74. PubMed ID: 12352185
[TBL] [Abstract] [Full Text] [Related]
15. Small cell carcinoma of the uterine cervix--an uncommon variant of cervical cancer with neuroendocrine features.
Lenczewski A; Terlikowski S; Sulkowska M; Famulski W; Kisielewski W; Kulikowski M
Folia Histochem Cytobiol; 2001; 39 Suppl 2():89-90. PubMed ID: 11820641
[TBL] [Abstract] [Full Text] [Related]
16. Alteration of p16 and p15 genes in human uterine tumours.
Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
[TBL] [Abstract] [Full Text] [Related]
17. Neuroendocrine differentiation in cervical carcinoma.
Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
[TBL] [Abstract] [Full Text] [Related]
18. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract] [Full Text] [Related]